Glasgow, United Kingdom

Emmanuel Oliver

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Common Services Agency, University of Glasgow. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emmanuel Oliver. Retrieved from https://idiyas.com/inventor/emmanuel-oliver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emmanuel Oliver - Innovator in Erythroid Production

Introduction

Emmanuel Oliver is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of stem cell research, particularly in the differentiation of stem cells into erythroid cells. His innovative approach has the potential to impact various medical applications.

Latest Patents

Emmanuel Oliver holds a patent for his invention titled "Erythroid production." This invention provides a method and media suitable for inducing and supporting the differentiation of stem cells into erythroid cells. His work in this area is groundbreaking and showcases his expertise in stem cell technology.

Career Highlights

Throughout his career, Emmanuel has worked with reputable organizations, including the Common Services Agency and the University of Glasgow. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Emmanuel has collaborated with various professionals in his field, including his coworker Joanne Mountford. Their joint efforts have furthered research and development in erythroid production and stem cell differentiation.

Conclusion

Emmanuel Oliver is a distinguished inventor whose work in erythroid production exemplifies the potential of stem cell research. His contributions are paving the way for future innovations in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…